ZIVO Bioscience, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZIVO research report →
About the company
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods.
- CEO
- John Bernard Payne
- IPO
- 2003
- Employees
- 7
- HQ
- Bloomfield Hills, MI, US
Price Chart
- Market Cap
- $20.42M
- P/E
- -2.03
- P/S
- 171.52
- P/B
- -5.44
- EV/EBITDA
- -2.13
- Div Yield
- 0.00%
- Gross Margin
- 32.94%
- Op Margin
- -8279.45%
- Net Margin
- -8311.12%
- ROE
- 353.53%
- ROIC
- 316.79%
- Revenue
- $119.03K · -24.29%
- Net Income
- $-9,892,305 · 26.09%
- EPS
- $-2.59 · 33.93%
- Op Income
- $-9,853,893
- FCF YoY
- 23.80%
- 52W High
- $19.65
- 52W Low
- $1.11
- 50D MA
- $3.61
- 200D MA
- $8.30
- Beta
- 0.09
- Avg Volume
- 3.76K
Get TickerSpark's AI analysis on ZIVO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 26 | STROME MARK E | buy | 100,000 |
| Feb 27, 26 | YALDOO LAITH L | buy | 1,543 |
| Feb 12, 26 | STROME MARK E | buy | 20,000 |
| Feb 12, 26 | STROME MARK E | buy | 2,000 |
| Feb 10, 26 | YALDOO LAITH L | buy | 2,434 |
| Jan 26, 26 | Cornell Alison A | buy | 11,709 |
| Jan 26, 26 | PAYNE JOHN BERNARD | buy | 11,709 |
| Jan 14, 26 | Maggiore Christopher D. | buy | 1,766 |
| Jan 14, 26 | YALDOO LAITH L | buy | 1,766 |
| Dec 19, 25 | Sullivan William A. | other | 0 |
Our ZIVO coverage
Recent articles, reports, and earnings notes.
No research on ZIVO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZIVO report →Similar companies
Peers in the same neighborhood.